Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2020

Open Access 01-08-2020 | Mononucleosis | Original Article

Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection

Authors: Jiang Qian, Qinhua Yu, Guoqing Chen, Mingxia Wang, Zhao Zhao, Yueyue Zhang, Liannv Qiu

Published in: Clinical and Experimental Medicine | Issue 3/2020

Login to get access

Abstract

Follicular help T cells (Tfh) play an important role in the activation and differentiation of B cells, while follicular regulatory T cells (Tfr) control Tfh and resulting humoral immune responses. Accumulating evidence has demonstrated that the dysregulation of Tfr contributed to the pathogenesis of infectious diseases. However, the role of Tfr in Epstein–Barr virus (EBV) infection remains lacking. Fifty-five EBV-infected infectious mononucleosis (IM) patients and 21 healthy individuals (HIs) were recruited in the study. We investigated the number of Tfr (FoxP3+CXCR5+PD-1+CD4+) and Tfh (FoxP3CXCR5+PD-1+CD4+) of peripheral blood in IM patients at diagnosis (D0) and day 15 after diagnosis (D15) via multicolor flow cytometry. Results revealed that circulating Tfh (cTfh) and Tfr (cTfr) of IM at D0 were both increased compared to HIs, and cTfr began to decline and return to normal at D15, while cTfh was still higher than those of HIs. More interestingly, the cTfr/cTfh ratio of IM at D0 and D15 was lower than that of HIs, suggesting that the balance between cTfh and cTfr was disturbed during primary EBV infection. Correlation analysis showed a positive correlation between cTfr with CD19+IgD+CD27 naive B cells, CD19+IgDCD27hi plasmablasts or CD19+CD24hiCD27hi B cells. Moreover, both cTfr and the cTfr/cTfh ratio of IM at D0 were negatively correlated with EBV DNA virus load. These results indicate that an imbalance of cTfr and cTfh cells may be involved in the immunopathogenesis of EBV-infected IM patients and may provide novel strategies for controlling EBV-related disease.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Babcock GJ, Decker LL, Volk M, et al. EBV persistence in memory b cells in vivo. Immunity. 1998;9(3):395–404.PubMedCrossRef Babcock GJ, Decker LL, Volk M, et al. EBV persistence in memory b cells in vivo. Immunity. 1998;9(3):395–404.PubMedCrossRef
3.
go back to reference Rickinson AB, Long HM, Palendira U, et al. Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 2014;35(4):159–169.PubMedCrossRef Rickinson AB, Long HM, Palendira U, et al. Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 2014;35(4):159–169.PubMedCrossRef
4.
go back to reference Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):23–36.PubMedCrossRef Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):23–36.PubMedCrossRef
5.
go back to reference Coskun O, Sener K, Kilic S, Erdem H, Yaman H, Besirbellioglu AB, Gul HC, Eyigun CP. Stress-related Epstein–Barr virus reactivation. Clin Exp Med. 2010;10(1):15–20.PubMedCrossRef Coskun O, Sener K, Kilic S, Erdem H, Yaman H, Besirbellioglu AB, Gul HC, Eyigun CP. Stress-related Epstein–Barr virus reactivation. Clin Exp Med. 2010;10(1):15–20.PubMedCrossRef
6.
go back to reference Longnecker R, Neipel F. Introduction to the human γ-herpesviruses. In: Human herpesviruses: biology, therapy, and immunoprophylaxis. 2007;Chapter 22. Longnecker R, Neipel F. Introduction to the human γ-herpesviruses. In: Human herpesviruses: biology, therapy, and immunoprophylaxis. 2007;Chapter 22.
7.
go back to reference Posnett DN. Herpesviruses and autoimmunity. Curr Opin Investig Drugs. 2008;9(5):505–514.PubMed Posnett DN. Herpesviruses and autoimmunity. Curr Opin Investig Drugs. 2008;9(5):505–514.PubMed
8.
go back to reference Szkaradkiewicz A, Kruk-Zagajewska A, Wal M, Jopek A, Wierzbicka M, Kuch A. Epstein–Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin Exp Med. 2002;2(3):137–241.PubMedCrossRef Szkaradkiewicz A, Kruk-Zagajewska A, Wal M, Jopek A, Wierzbicka M, Kuch A. Epstein–Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin Exp Med. 2002;2(3):137–241.PubMedCrossRef
12.
go back to reference Fazilleau N, Aloulou M. Several follicular regulatory t cell subsets with distinct phenotype and function emerge during germinal center reactions. Front Immunol. 2018;9:1792.PubMedPubMedCentralCrossRef Fazilleau N, Aloulou M. Several follicular regulatory t cell subsets with distinct phenotype and function emerge during germinal center reactions. Front Immunol. 2018;9:1792.PubMedPubMedCentralCrossRef
15.
go back to reference Niu Q, Huang ZC, Wu XJ, et al. Enhanced il-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):200–208.PubMedPubMedCentralCrossRef Niu Q, Huang ZC, Wu XJ, et al. Enhanced il-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):200–208.PubMedPubMedCentralCrossRef
16.
go back to reference Chen M, Lin X, Cheukfai L, et al. Advances in t follicular helper and t follicular regulatory cells in transplantation immunity. Transplant Rev (Orlando). 2018;32(4):187–193.CrossRef Chen M, Lin X, Cheukfai L, et al. Advances in t follicular helper and t follicular regulatory cells in transplantation immunity. Transplant Rev (Orlando). 2018;32(4):187–193.CrossRef
17.
go back to reference Fonseca VR, Agua-Doce A, Maceiras AR, et al. Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function. Sci Immunol. 2017;2(14):eaan1487.PubMedCrossRef Fonseca VR, Agua-Doce A, Maceiras AR, et al. Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function. Sci Immunol. 2017;2(14):eaan1487.PubMedCrossRef
18.
go back to reference Baptista D, Mach F, Brandt KJ. Follicular regulatory t cell in atherosclerosis. J Leukoc Biol. 2018;104(5):925–930.PubMedCrossRef Baptista D, Mach F, Brandt KJ. Follicular regulatory t cell in atherosclerosis. J Leukoc Biol. 2018;104(5):925–930.PubMedCrossRef
19.
go back to reference He J, Tsai LM, Leong YA, et al. Circulating precursor CCR7(lo)Pd-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770–781.PubMedCrossRef He J, Tsai LM, Leong YA, et al. Circulating precursor CCR7(lo)Pd-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770–781.PubMedCrossRef
20.
21.
go back to reference Sage PT, Alvarez D, Godec J, et al. Circulating t follicular regulatory and helper cells have memory-like properties. J Clin Investig. 2014;124(12):5191–5204.PubMedCrossRef Sage PT, Alvarez D, Godec J, et al. Circulating t follicular regulatory and helper cells have memory-like properties. J Clin Investig. 2014;124(12):5191–5204.PubMedCrossRef
22.
go back to reference Wu X, Su Z, Cai B, et al. Increased circulating follicular regulatory t-like cells may play a critical role in chronic hepatitis b virus infection and disease progression. Viral Immunol. 2018;31(5):379–388.PubMedCrossRef Wu X, Su Z, Cai B, et al. Increased circulating follicular regulatory t-like cells may play a critical role in chronic hepatitis b virus infection and disease progression. Viral Immunol. 2018;31(5):379–388.PubMedCrossRef
23.
go back to reference Wang L, Qiu J, Yu L, et al. Increased numbers of CD5+ CD19+ CD1d high IL-10+ Bregs, CD4+ Foxp3+ Tregs, CD4+ CXCR5+ Foxp3+ follicular regulatory T (Tfr) cells in CHB or CHC patients. J Transl Med. 2014;12:251.PubMedPubMedCentralCrossRef Wang L, Qiu J, Yu L, et al. Increased numbers of CD5+ CD19+ CD1d high IL-10+ Bregs, CD4+ Foxp3+ Tregs, CD4+ CXCR5+ Foxp3+ follicular regulatory T (Tfr) cells in CHB or CHC patients. J Transl Med. 2014;12:251.PubMedPubMedCentralCrossRef
24.
go back to reference Miles B, Miller SM, Folkvord JM, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608.PubMedPubMedCentralCrossRef Miles B, Miller SM, Folkvord JM, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608.PubMedPubMedCentralCrossRef
25.
go back to reference Botta D, Fuller MJ, Marquez-Lago TT, et al. Dynamic regulation of t follicular regulatory cell responses by interleukin 2 during influenza infection. Nat Immunol. 2017;18(11):1249–1260.PubMedPubMedCentralCrossRef Botta D, Fuller MJ, Marquez-Lago TT, et al. Dynamic regulation of t follicular regulatory cell responses by interleukin 2 during influenza infection. Nat Immunol. 2017;18(11):1249–1260.PubMedPubMedCentralCrossRef
26.
go back to reference Dhaeze T, Peelen E, Hombrouck A, et al. Circulating follicular regulatory t cells are defective in multiple sclerosis. J Immunol. 2015;195(3):832–840.PubMedCrossRef Dhaeze T, Peelen E, Hombrouck A, et al. Circulating follicular regulatory t cells are defective in multiple sclerosis. J Immunol. 2015;195(3):832–840.PubMedCrossRef
27.
go back to reference Xu B, Wang S, Zhou M, et al. The ratio of circulating follicular t helper cell to follicular t regulatory cell is correlated with disease activity in systemic lupus erythematosus. Clin Immunol. 2017;183:46–53.PubMedPubMedCentralCrossRef Xu B, Wang S, Zhou M, et al. The ratio of circulating follicular t helper cell to follicular t regulatory cell is correlated with disease activity in systemic lupus erythematosus. Clin Immunol. 2017;183:46–53.PubMedPubMedCentralCrossRef
28.
go back to reference Liu C, Wang D, Lu S, et al. Increased circulating follicular treg cells are associated with lower levels of autoantibodies in patients with rheumatoid arthritis in stable remission. Arthritis Rheumatol. 2018;70(5):711–721.PubMedCrossRef Liu C, Wang D, Lu S, et al. Increased circulating follicular treg cells are associated with lower levels of autoantibodies in patients with rheumatoid arthritis in stable remission. Arthritis Rheumatol. 2018;70(5):711–721.PubMedCrossRef
29.
go back to reference Liu J, Zhou Y, Yu Q, et al. Higher frequency of CD4+ CXCR5+ ICOS+ PD1+ T follicular helper cells in patients with infectious mononucleosis. Med (Baltim). 2015;94(45):e2061.CrossRef Liu J, Zhou Y, Yu Q, et al. Higher frequency of CD4+ CXCR5+ ICOS+ PD1+ T follicular helper cells in patients with infectious mononucleosis. Med (Baltim). 2015;94(45):e2061.CrossRef
30.
go back to reference Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530–541.PubMedPubMedCentralCrossRef Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530–541.PubMedPubMedCentralCrossRef
31.
go back to reference Blair PA, Norena LY, Flores-Borja F, et al. CD19(+) CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129–140.PubMedCrossRef Blair PA, Norena LY, Flores-Borja F, et al. CD19(+) CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129–140.PubMedCrossRef
32.
go back to reference Laidlaw BJ, Lu Y, Amezquita RA, et al. Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response. Sci Immunol. 2017;2(16):eaan4767.PubMedPubMedCentralCrossRef Laidlaw BJ, Lu Y, Amezquita RA, et al. Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response. Sci Immunol. 2017;2(16):eaan4767.PubMedPubMedCentralCrossRef
33.
go back to reference Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569–5579.PubMedCrossRef Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569–5579.PubMedCrossRef
34.
go back to reference Li H, Zhou R, Wang C, et al. T follicular regulatory cells infiltrate the human airways during the onset of acute respiratory distress syndrome and regulate the development of B regulatory cells. Immunol Res. 2018;66(4):548–554.PubMedPubMedCentralCrossRef Li H, Zhou R, Wang C, et al. T follicular regulatory cells infiltrate the human airways during the onset of acute respiratory distress syndrome and regulate the development of B regulatory cells. Immunol Res. 2018;66(4):548–554.PubMedPubMedCentralCrossRef
35.
go back to reference Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8(+) T cell function in vitro. J Leukoc Biol. 2013;93(5):811–818.PubMedPubMedCentralCrossRef Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8(+) T cell function in vitro. J Leukoc Biol. 2013;93(5):811–818.PubMedPubMedCentralCrossRef
Metadata
Title
Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection
Authors
Jiang Qian
Qinhua Yu
Guoqing Chen
Mingxia Wang
Zhao Zhao
Yueyue Zhang
Liannv Qiu
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 3/2020
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-020-00621-8

Other articles of this Issue 3/2020

Clinical and Experimental Medicine 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.